Help:Cleanup
From BugSigDB
This page assists editors with cleanup of certain outstanding wiki issues. It has lots of heavy queries so it may take a while to load or purge.
Links to lists of pages[edit]
Duplicate Studies[edit]
Orphaned Experiments[edit]
Orphaned Signatures[edit]
Studies that have no Experiments[edit]
- Effect of ethnicity and socioeconomic variation to the gut microbiota composition among pre-adolescent in Malaysia
- Effect of ethnicity and socioeconomic variation to the gut microbiota composition among pre-adolescent in Malaysia
- Exercise Alters Gut Microbiota Composition and Function in Lean and Obese Humans
- Exercise Alters Gut Microbiota Composition and Function in Lean and Obese Humans
- Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients
- Glycosphingolipid compositions of human T-lymphotropic virus type I (HTLV-I) and human immunodeficiency virus (HIV)-infected cell lines
- Gut Microbiome and the Response to Immunotherapy in Cancer
- Gut Microbiome Changes Associated With HIV Infection and Sexual Orientation
- Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation
- Gut Microbiome of Healthy and Arthritic Dogs
- Gut microbiome, antibiotic use, and immunotherapy responsiveness in cancer
- Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
- Gut microbiota: impacts on gastrointestinal cancer immunotherapy
- Harness the functions of gut microbiome in tumorigenesis for cancer treatment
- HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases
- Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population
- Metaproteomics characterizes human gut microbiome function in colorectal cancer
- Microbiome recovery in adult females with uncomplicated urinary tract infections in a randomised phase 2A trial of the novel antibiotic gepotidacin (GSK140944)
- Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients
- Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
- Oral microbiome in HIV-associated periodontitis
- Perturbations of the Gut Microbiome and Metabolome in Children with Calcium Oxalate Kidney Stone Disease
- Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer
- Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome
- Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis
- Signatures of COVID-19 severity and immune response in the respiratory tract microbiome
- Study 664
- Study 668
- Suppression of the gut microbiome ameliorates age-related arterial dysfunction and oxidative stress in mice
- The clinical outcomes of medical therapies in chronic rhinosinusitis are independent of microbiomic outcomes: a double-blinded, randomised placebo-controlled trial
- The Gut Microbiome and Cancer Immunotherapy: Can We Use the Gut Microbiome as a Predictive Biomarker for Clinical Response in Cancer Immunotherapy?
- The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
- Unculturable and culturable periodontal-related bacteria are associated with periodontal inflammation during pregnancy and with preterm low birth weight delivery
Experiments that have no Signatures[edit]
- Age-specific differential changes on gut microbiota composition in patients with major depressive disorder/Experiment 1
- Alteration of salivary microbiome in periodontitis with or without type-2 diabetes mellitus and metformin treatment/Experiment 3
- Alterations in the human oral and gut microbiomes and lipidomics in COVID-19/Experiment 4
- Alterations of gut microbiome in autoimmune hepatitis/Experiment 2
- Altered composition of the gut microbiome in patients with drug-resistant epilepsy/Experiment 2
- Antibiotics at birth and later antibiotic courses: effects on gut microbiota/Experiment 1
- Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment/Experiment 4
- Characteristics of the intestinal flora in patients with peripheral neuropathy associated with type 2 diabetes/Experiment 2
- Characteristics of the intestinal flora in patients with peripheral neuropathy associated with type 2 diabetes/Experiment 3
- Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota/Experiment 3
- Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota/Experiment 4
- Collateral damage from oral ciprofloxacin versus nitrofurantoin in outpatients with urinary tract infections: a culture-free analysis of gut microbiota/Experiment 5
- Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life/Experiment 8
- Comparative analysis of racial differences in breast tumor microbiome/Experiment 3
- Correction to: Microbiome recovery in adult females with uncomplicated urinary tract infections in a randomised phase 2A trial of the novel antibiotic gepotidacin (GSK2140944)/Experiment 1
- Delivery Mode and the Transition of Pioneering Gut-Microbiota Structure, Composition and Predicted Metabolic Function/Experiment 2
- Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns/Experiment 1
- Differences in foot skin microbiomes between patients with type 2 diabetes and healthy individuals/Experiment 2
- Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome/Experiment 2
- Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome/Experiment 3
- Effect of endometriosis on the fecal bacteriota composition of mice during the acute phase of lesion formation/Experiment 1
- Effect of ethnicity and socioeconomic variation to the gut microbiota composition among pre-adolescent in Malaysia/Experiment 1
- Effects of amoxicillin treatment on the salivary microbiota in children with acute otitis media/Experiment 1
- Enriched Opportunistic Pathogens Revealed by Metagenomic Sequencing Hint Potential Linkages between Pharyngeal Microbiota and COVID-19/Experiment 2
- Enriched Opportunistic Pathogens Revealed by Metagenomic Sequencing Hint Potential Linkages between Pharyngeal Microbiota and COVID-19/Experiment 3
- Evaluation of superinfection, antimicrobial usage, and airway microbiome with metagenomic sequencing in COVID-19 patients: A cohort study in Shanghai/Experiment 2
- Factors Associated With the Microbiome in Moderate-Late Preterm Babies: A Cohort Study From the DIAMOND Randomized Controlled Trial/Experiment 1
- Fecal microbiome signatures of pancreatic cancer patients/Experiment 2
- Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients/Experiment 4
- Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study/Experiment 4
- Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study/Experiment 11
- Gut mucosal microbiome across stages of colorectal carcinogenesis/Experiment 6
- High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome/Experiment 3
- HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases/Experiment 1
- Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccination/Experiment 1
- Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington's disease/Experiment 1
- Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients/Experiment 2
- Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients/Experiment 3
- Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients/Experiment 4
- Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery/Experiment 1
- Metagenome-wide association of gut microbiome features for schizophrenia/Experiment 6
- Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome/Experiment 1
- Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients/Experiment 1
- Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy/Experiment 1
- Oral microbiome and history of smoking and colorectal cancer/Experiment 1
- Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer/Experiment 1
- SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition/Experiment 1
- Six-month follow-up of gut microbiota richness in patients with COVID-19/Experiment 1
- Six-month follow-up of gut microbiota richness in patients with COVID-19/Experiment 2
- Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 1
- Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 2
- Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 3
- Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 4
- Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 5
- Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 6
- Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults/Experiment 7
- The clinical outcomes of medical therapies in chronic rhinosinusitis are independent of microbiomic outcomes: a double-blinded, randomised placebo-controlled trial/Experiment 1
- The impact of NBUVB on microbial community profiling in the lesional skin of vitiligo subjects/Experiment 1
- The impact of NBUVB on microbial community profiling in the lesional skin of vitiligo subjects/Experiment 2
- The impact of NBUVB on microbial community profiling in the lesional skin of vitiligo subjects/Experiment 3
- The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing/Experiment 1
- The potential of fecal microbiota and amino acids to detect and monitor patients with adenoma/Experiment 2
- Tumour-associated and non-tumour-associated microbiota in colorectal cancer/Experiment 1
- [The cytochromes of cytoplasmic and mesosomal membranes of Bacillus subtilis]/Experiment 1
- [The cytochromes of cytoplasmic and mesosomal membranes of Bacillus subtilis]/Experiment 2
